Area of research
Hematology · Immunology
Research interest
Research interests include Medicine, Chemistry, Aplastic anemia, Clinical endpoint, Internal medicine, and Moiety.
Phase 3 randomized <scp>COMMODORE</scp> 2 trial: Crovalimab versus eculizumab in patients with <scp>paroxysmal nocturnal hemoglobinuria</scp> naive to complement inhibition
Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence
First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study
A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy
Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study
Identification of benzothiazones containing a hexahydropyrrolo[3,4-<i>c</i>]pyrrol moiety as antitubercular agents against MDR-MTB
A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents
hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents
Dual effects of human neutrophil peptides in a mouse model of pneumonia and ventilator-induced lung injury